ObjectiveTo examine the long-term effects of Sur KO, SSTR5 KO, and double Sur/SSTR5 KO on insulin secretion and glucose regulation.
Summary Background DataThe sulfonylurea receptor (Sur) and somatostatin receptor type 5 (SSTR5) play an integral role in the regulatory pathways of the endocrine pancreas. Sur knockout (KO) and SSTR5 KO mice were generated in the authors' laboratories and crossbred to generate Sur/SSTR5 KO mice. All mice were genotyped by Southern blotting and polymerase chain reaction analysis.
MethodsOne-year-old Sur KO, Sur/SSTR5 KO, SSTR5 KO, and agematched wild-type control mice underwent single-pass perfusion of isolated pancreata with low and high glucose concentration (n ϭ 4 -6/group). Another group of mice also underwent intraperitoneal glucose tolerance tests with 1.2 g glucose/kg body weight (n ϭ 4/group per time point).
ResultsSur1 KO and Sur/SSTR5 KO mice had profoundly decreased insulin secretion in vitro, whereas SSTR5 KO had increased insulin secretion compared with wild-type mice. Sur1 KO and Sur/SSTR5 mice had increased glucose response in vivo compared with wild-type mice. Sur1 KO and Sur/SSTR5 KO mice exhibit glucose intolerance and SSTR5 KO mice show increased insulin response in vitro.
ConclusionsSur1 KO causes glucose intolerance and SSTR5 KO causes increased insulin secretion. However, Sur/SSTR5 double ablation does not alleviate the diabetic state of the Sur1 KO.The endocrine pancreas consists of the islets of Langerhans, which are in turn made up of several different cell types. The most common cell type in the islets are the beta cells, which make up 70% of the volume of the islet and are responsible for the secretion of insulin. Other cell types include the alpha cells, which produce glucagon, and the delta cells, which produce somatostatin. These two groups make up approximately 20% and 5%, respectively, of the volume of the islet.